Zeria Pharmaceutical Co., Ltd. (4559.T)

JPY 2454.0

(1.95%)

Revenue Summary of Zeria Pharmaceutical Co., Ltd.

  • Zeria Pharmaceutical Co., Ltd.'s latest annual revenue in 2023 was 75.72 Billion JPY , up 10.74% from previous year.
  • Zeria Pharmaceutical Co., Ltd.'s latest quarterly revenue in 2024 Q1 was 21.45 Billion JPY , up 20.49% from previous quarter.
  • Zeria Pharmaceutical Co., Ltd. reported a annual revenue of 68.38 Billion JPY in annual revenue 2022, up 14.87% from previous year.
  • Zeria Pharmaceutical Co., Ltd. reported a annual revenue of 59.53 Billion JPY in annual revenue 2021, up 7.4% from previous year.
  • Zeria Pharmaceutical Co., Ltd. reported a quarterly revenue of 18.3 Billion JPY for 2023 Q1, up 9.91% from previous quarter.
  • Zeria Pharmaceutical Co., Ltd. reported a quarterly revenue of 75.72 Billion JPY for 2023 FY, up 10.74% from previous quarter.

Annual Revenue Chart of Zeria Pharmaceutical Co., Ltd. (2023 - 2005)

Historical Annual Revenue of Zeria Pharmaceutical Co., Ltd. (2023 - 2005)

Year Revenue Revenue Growth
2023 75.72 Billion JPY 10.74%
2022 68.38 Billion JPY 14.87%
2021 59.53 Billion JPY 7.4%
2020 55.43 Billion JPY -8.28%
2019 60.43 Billion JPY -2.25%
2018 61.82 Billion JPY -4.26%
2017 64.57 Billion JPY -0.44%
2016 64.86 Billion JPY 3.81%
2015 62.47 Billion JPY 2.32%
2014 61.06 Billion JPY -1.5%
2013 61.99 Billion JPY 16.25%
2012 53.32 Billion JPY 0.25%
2011 53.19 Billion JPY 7.43%
2010 49.51 Billion JPY -2.46%
2009 50.76 Billion JPY 6.49%
2008 47.66 Billion JPY -4.19%
2007 49.75 Billion JPY -5.7%
2006 52.76 Billion JPY -5.04%
2005 55.56 Billion JPY 0.0%

Peer Revenue Comparison of Zeria Pharmaceutical Co., Ltd.

Name Revenue Revenue Difference
Pharma Foods International Co., Ltd. 62.14 Billion JPY -21.848%
Takeda Pharmaceutical Company Limited 4263.76 Billion JPY 98.224%
Sumitomo Pharma Co., Ltd. 314.55 Billion JPY 75.927%
Shionogi & Co., Ltd. 435.08 Billion JPY 82.595%
Wakamoto Pharmaceutical Co.,Ltd. 7.73 Billion JPY -878.559%
Nippon Shinyaku Co., Ltd. 148.25 Billion JPY 48.922%
Kaken Pharmaceutical Co., Ltd. 72.04 Billion JPY -5.109%
Eisai Co., Ltd. 741.75 Billion JPY 89.791%
Morishita Jintan Co., Ltd. 12.4 Billion JPY -510.391%
Hisamitsu Pharmaceutical Co., Inc. 141.7 Billion JPY 46.562%
Mochida Pharmaceutical Co., Ltd. 102.88 Billion JPY 26.398%
Fuso Pharmaceutical Industries,Ltd. 55.4 Billion JPY -36.673%
Nippon Chemiphar Co., Ltd. 30.74 Billion JPY -146.276%
Tsumura & Co. 150.84 Billion JPY 49.799%
Kissei Pharmaceutical Co., Ltd. 75.57 Billion JPY -0.193%
Torii Pharmaceutical Co., Ltd. 54.63 Billion JPY -38.594%
Towa Pharmaceutical Co., Ltd. 227.93 Billion JPY 66.778%
Fuji Pharma Co., Ltd. 40.88 Billion JPY -85.197%
KYORIN Holdings, Inc. 119.53 Billion JPY 36.649%
Taiko Pharmaceutical Co.,Ltd. 5.04 Billion JPY -1402.482%
Daito Pharmaceutical Co.,Ltd. 46.89 Billion JPY -61.478%
SymBio Pharmaceuticals Limited 5.58 Billion JPY -1254.723%
MedRx Co., Ltd 26 Million JPY -291150.288%
Mizuho Medy Co.,Ltd. 10.98 Billion JPY -589.053%
Solasia Pharma K.K. 617 Million JPY -12173.108%
Modalis Therapeutics Corporation - JPY -Infinity%
ASKA Pharmaceutical Holdings Co.,Ltd. 62.84 Billion JPY -20.499%
Sawai Group Holdings Co., Ltd. 176.86 Billion JPY 57.184%
Cyfuse Biomedical K.K. 61.11 Million JPY -123811.957%
Toho Holdings Co., Ltd. 1476.71 Billion JPY 94.872%
Koa Shoji Holdings Co.,Ltd. 22.13 Billion JPY -242.119%